WCG Clinical
Private Company
Funding information not available
Overview
WCG Clinical is a long-established, private company and a dominant force in the clinical trial services sector, with a 55+ year legacy originating from its founding role in independent ethical review (IRB). The company has evolved into a comprehensive solutions provider, leveraging a vast proprietary dataset, AI-powered analytics via its ClinSphere® platform, and a full suite of services spanning study planning, site feasibility, participant recruitment, and training. Trusted by 94% of companies with FDA-approved drugs in the last five years, WCG aims to address critical industry bottlenecks in study startup, enrollment, and site burden to get therapies to market faster.
Technology Platform
WCG ClinSphere®: An integrated ecosystem of tech-enabled clinical trial solutions and intelligence, powered by AI and a proprietary database of 80,000+ protocols. Key components include AI-powered foresight (Trial IntelX™), IRB workflow management (eReview Manager), and integrated modules for feasibility, enrollment, and training.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
WCG competes in a fragmented market including large, full-service Contract Research Organizations (CROs) like IQVIA and ICON that offer overlapping services; standalone eClinical software providers like Veeva and Medidata; and a growing array of niche technology startups focused on AI, patient recruitment, or site enablement. WCG's differentiation lies in its unique combination of foundational IRB services, a vast proprietary dataset, and an integrated platform strategy.